JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.17% |
| 2 | Healthcare | 10.79% |
| 3 | Financials | 9.36% |
| 4 | Consumer Discretionary | 8.67% |
| 5 | Industrials | 7.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2076
Ultragenyx Pharmaceutical
RARE
$2.61B
| $11.6M | ﹤0.01% |
289,068
-6,087
| -2% | -$261K |
|
|
HMA
2077
DELISTED
Heartland Media Acquisition Corp.
HMA
| $11.6M | ﹤0.01% |
+1,111,000
| New | +$11.5M |
|
2078
CALL
Monster Beverage
MNST
$91.7B
| $11.5M | ﹤0.01% |
426,800
+373,200
| +696% | +$9.57M |
|
|
VRTV
2079
DELISTED
VERITIV CORPORATION
VRTV
| $11.5M | ﹤0.01% |
85,045
-20,809
| -20% | -$2.67M |
|
2080
Skywest
SKYW
$4.18B
| $11.5M | ﹤0.01% |
516,776
-194,058
| -27% | -$3.8M |
|
2081
GSK
GSK
$99.2B
| $11.4M | ﹤0.01% |
321,559
+44,633
| +16% | +$1.56M |
|
2082
US Physical Therapy
USPH
$1.21B
| $11.4M | ﹤0.01% |
116,812
+22,341
| +24% | +$2.13M |
|
2083
CALL
Palo Alto Networks
PANW
$313B
| $11.4M | ﹤0.01% |
114,400
-86,600
| -43% | -$7.34M |
|
2084
Gibraltar Industries
ROCK
$1.42B
| $11.4M | ﹤0.01% |
235,567
+203,334
| +631% | +$10.4M |
|
2085
Franklin Electric
FELE
$4.68B
| $11.4M | ﹤0.01% |
120,855
+24,283
| +25% | +$2.19M |
|
2086
Associated Banc-Corp
ASB
$6.11B
| $11.3M | ﹤0.01% |
631,255
-12,227
| -2% | -$268K |
|
2087
Repay Holdings
RPAY
$303M
| $11.3M | ﹤0.01% |
1,726,300
+171,353
| +11% | +$1.41M |
|
|
XAGE
2088
DELISTED
Longevity Health Holdings, Inc. Common Stock
XAGE
| $11.3M | ﹤0.01% |
+37,233
| New | +$11.2M |
|
2089
Texas Pacific Land
TPL
$24.7B
| $11.3M | ﹤0.01% |
59,976
+3,249
| +6% | +$677K |
|
2090
Patrick Industries
PATK
$2.76B
| $11.3M | ﹤0.01% |
246,198
-158,967
| -39% | -$7.37M |
|
2091
Marten Transport
MRTN
$1.24B
| $11.3M | ﹤0.01% |
538,677
+101,865
| +23% | +$2.17M |
|
2092
Safety Insurance
SAFT
$1.52B
| $11.3M | ﹤0.01% |
151,273
-49,989
| -25% | -$4.07M |
|
2093
Teva Pharmaceuticals
TEVA
$42.8B
| $11.3M | ﹤0.01% |
1,271,900
+660,539
| +108% | +$6.53M |
|
|
GES
2094
DELISTED
Guess Inc
GES
| $11.2M | ﹤0.01% |
575,684
-311,788
| -35% | -$6.69M |
|
|
RETA
2095
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $11.2M | ﹤0.01% |
123,243
-44,173
| -26% | -$2.59M |
|
|
AJRD
2096
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $11.2M | ﹤0.01% |
198,851
+54,795
| +38% | +$3.07M |
|
2097
Leggett & Platt
LEG
$1.32B
| $11.2M | ﹤0.01% |
350,161
+95,620
| +38% | +$3.22M |
|
2098
DraftKings
DKNG
$13B
| $11.1M | ﹤0.01% |
575,702
+223,336
| +63% | +$3.71M |
|
2099
Antero Midstream
AM
$10.7B
| $11.1M | ﹤0.01% |
1,060,309
+53,436
| +5% | +$568K |
|
2100
PUT
MGM Resorts International
MGM
$11.1B
| $11.1M | ﹤0.01% |
250,000
+205,500
| +462% | +$8.54M |
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 752 new, 3,315 increased, 2,057 reduced and 651 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 752 new positions and closed 651 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.